KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 01/02/2021

    Tell the Netherlands to invest in healthcare worldwide

    It’s become clear to everyone now; diseases know no borders. COVID-19 has shaken the whole world up about the importance…

    Lees meer
  • 22/01/2021

    Tajikistan’s tuberculosis patients receive groundbreaking new treatment

    Tajikistan is the first country in Central Asia to provide people with tuberculosis (TB)  access to  the groundbreaking new BPaL…

    Lees meer
  • 21/01/2021

    TB expert Max Meis: “My career is characterized by pandemics”

    After 11 years at KNCV Tuberculosis Foundation, Dutch TB expert Max Meis (66) is closing the virtual office door behind…

    Lees meer
  • Newsletter

    Subscribe Would you like to stay informed about KNCV projects, news and activities? Sign…

    Lees meer
  • 13/01/2021

    How digital technologies can empower patients to succeed in TB treatment

    The run-in phase of the ASCENT project has started, enrolling TB patients on digital adherence technologies in the Philippines…

    Lees meer
  • 15/12/2020

    Fear of TB infection can lead to stigma

    The recent research ‘Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the…

    Lees meer
  • Malawi, Ethiopia and Indonesia are leading the way

    For the first time in 2020 the new 3HP regimen for prevention of TB will be taken into the TB…

    Lees meer
  • 23/11/2020

    New treatment offers hope for XDR-TB patient Hanna

    Hanna from Ukraine is one of the first TB patients in the world to be treated with a new, groundbreaking…

    Lees meer
  • 23/11/2020

    Ukraine TB patients first to receive groundbreaking new drug regimen

    Ukraine is the first country in the world to provide tuberculosis (TB) patients with the groundbreaking new BPaL treatment in…

    Lees meer
  • 12/11/2020

    Smart medication container included in GDF product catalog

    Stop TB Partnership’s Global Drug Facility (GDF) and the Unitaid-funded Adherence Support Coalition to End TB (ASCENT project) announce the…

    Lees meer
  • Good proportion of household contact children age < 5yrs were TB screened but not getting preventive therapy in Ethiopia

    E-poster presented during the Union World Conference 2020. Authors: A. Umar, A. Omer, D. Jerene, D. Lemma, M. Godebo, KNCV…

    Lees meer
  • Does BCG Vaccination protect against TB infection in Vietnamese schoolchildren?

    E-poster presented during the Union World Conference 2020. Y. Smit, E.W. Tiemersma, N.T. Huong, N.V. Nhung, F. Cobelens,…

    Lees meer
  • Using Patient Pathway analysis in Rwanda: Methods, problems and the importance of data and sensitivity analysis

    E-poster presented during the Union World Conference 2020. Puck Pelzer, Sarah van de Berg, Augustin Dushime, Patrick Migambi,…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.